November 4, 2022
Teva Pharmaceutical Industries Lts. will pay up to $523 million to New York State as part of a nationwide settlement of lawsuits alleging the company helped fuel the U.S. opioid epidemic. The settlement with New York adds an additional $300 …
July 11, 2022
New York’s attorney general on Monday said Teva Pharmaceutical Industries Ltd. lied to evade accountability for helping fuel the state’s opioid crisis, and should be restored to litigation where the Israeli company’s U.S. unit had been found liable. In a …
March 22, 2022
Rhode Island’s attorney general on Monday announced settlements he valued at $107 million against the drugmakers Teva Pharmaceutical Industries and AbbVie’s Allergan unit to resolve claims over their roles in fueling an opioid epidemic in the state. Attorney General Peter …
March 15, 2022
Rhode Island is set to square off on Monday against Teva Pharmaceutical Industries Ltd., as a multibillion-dollar trial begins over whether the Israeli company contributed to an opioid crisis that has caused more than 500,000 deaths over the past two …
January 3, 2022
Teva Pharmaceutical Industries Ltd. fueled opioid addiction in New York state, a jury found last Thursday, a setback for a company still facing thousands of other opioid-related lawsuits around the United States. The verdict, which followed a nearly six-month New …
December 9, 2021
AbbVie Inc. agreed to pay $200 million to settle claims by New York that its Allergan unit helped fuel an epidemic of opioid addiction in the state, shortly before jurors heard closing arguments from remaining defendant Teva Pharmaceutical Industries Ltd. …
October 5, 2020
A federal appeals court on Friday reinstated a 2017 jury verdict ordering Teva Pharmaceutical Industries Ltd. to pay GlaxoSmithKline Plc $235.5 million for selling a generic version of Glaxo’s heart drug Coreg. In a 2-1 decision, the U.S. Federal Circuit …
August 26, 2020
The U.S. Justice Department charged Teva Pharmaceutical Industries Ltd. on Tuesday with conspiring with competitors to raise prices for generic drugs. The Justice Department has been investigating allegations the company colluded with other drugmakers to push up the prices of …
October 21, 2019
Four large drug companies reached a last-minute $260 million legal settlement over their role in the U.S. opioid addiction epidemic, averting the first federal trial that was scheduled to start Monday morning in Cleveland. The settlement covers drug distributors and …
July 1, 2019
The U.S. government wants a portion of Oklahoma’s $270 million settlement with Purdue Pharma that stemmed from the state’s ongoing lawsuit against opioid makers. The U.S. Centers for Medicare and Medicaid Services wrote to the head of Oklahoma’s Medicaid agency …